Grant-Huerta Yanina 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Grant-Huerta Yanina（CIK 2064348）在 2 家公司共报告 15 笔 SEC Form 4 内部人交易（最近一笔 2026-08-17）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-17 | ImageneBio, Inc. (IMA) | Chief Financial Officer | 买入 | 65,000 | $0 |
| 2026-08-17 | ImageneBio, Inc. (IMA) | Chief Financial Officer | 买入 | 39,000 | $0 |
| 2026-05-20 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 2,414 | $22,040 |
| 2026-03-11 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 买入 | 20,300 | $0 |
| 2026-03-04 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 24 | $122 |
| 2026-03-04 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 1,603 | $8,143 |
| 2026-03-04 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 377 | $1,915 |
| 2026-03-04 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 100 | $508 |
| 2025-11-19 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 1,645 | $21,698 |
| 2025-11-19 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 85 | $1,121 |
| 2025-11-19 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 74 | $976 |
| 2025-08-20 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 55 | $639 |
| 2025-08-20 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 86 | $998 |
| 2025-08-20 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 1,668 | $19,365 |
| 2025-05-20 | Atara Biotherapeutics, Inc. (ATRA) | Chief Accounting Officer | 卖出 | 2,218 | $14,994 |
来源：SEC Form 4 申报文件 · 截至 2026-08-17